Dimery, his patient, underscoring Intima's impact on global healthNEW YORK and CAMBRIDGE, England, Feb. 11, 2026 ...

CD8⁺ T cells are the frontline soldiers of the body against cancer, but their prolonged exposure to tumor antigens often leads to an exhausted state ...

In a significant breakthrough for cancer immunotherapy, collaborative studies published simultaneously in Immunity & ...

Hyundai’s performance division is preparing a fresh wave of serious hardware, and the message from the top is clear: the N ...

ATI-2138 and ritlecitinib were assessed using a reversal model of murine alopecia universalis, the most severe AA phenotype. Mice were randomized to control or drug formulated in chow (100 or 300 ppm ...

The latest update is out from Immatics ( (IMTX) ).

Researchers from the Keck School of Medicine of USC have developed a new type of chimeric antigen receptor (CAR) T cell that elicits a more controlled immune response to cancer in mice—effectively ...

The study provides important mechanistic insight into the transcriptional control of γδT17 development, elegantly demonstrating how HEB and Id3 act sequentially and cooperatively to regulate γδT17 ...

Exclusive collaboration and license agreement focuses on advancing novel T cell therapy “Seed-and-Boost” approach exploiting the mechanism of the CUE-100 series of Immuno-STATs® Novel therapeutic ...